Hamed, Alaa
Curran, Christopher
Gwaltney, Chad
DasMahapatra, Pronabesh http://orcid.org/0000-0002-8242-0580
Funding for this research was provided by:
Sanofi
Article History
Received: 7 December 2018
Accepted: 19 June 2019
First Online: 22 July 2019
Competing interests
: A.H. and P.D. are employees of Sanofi Genzyme and own stocks in the company. P.D. was an employee at PatientsLikeMe and owns stocks in the company. C.C. was an employee at PatientsLikeMe and owns stock options in the company. C.G. is an employee at Gwaltney Consulting and received funding for this research from Sanofi Genzyme. The PatientsLikeMe Research Team has received research funding (including conference support and consulting fees) from Abbvie, Accorda, Actelion, Amgen, AstraZeneca, Avanir, Biogen, Boehringer Ingelheim, Genzyme, Genentech, Janssen, Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi, Takeda and UCB. The PatientsLikeMe R&D team has received research grant funding from Kaiser Permanente, the Robert Wood Johnson Foundation, Sage Bionetworks, The AKU Society, and the University of Maryland.